Background: Renal disease results in significant disorder of hemostasis (bleeding diathesis orhypercoagulable state).Objectives: This study is to determine the changes in some hemostasis parameters in patients withchronic renal failure and identify the effect of dialysis on these changes.Patients and Methods: seventy five patients with end stage chronic renal failure were collected fromBaghdad hospital, a full detailed history and clinical examination were performed, 50 patients were onmaintenance weekly hemodialysis, and 25 patients were without dialysis.Result: Bleeding time was significantly higher in patients with chronic renal failure who didn’t needany type of dialysis, positive D-Dimer test. In some patients, Platelet count, prothrombin time, thrombintime, fibrinogene level, activated partial thromboplastin time; all did not reach significant level betweenboth groups of patients.Conclusion: hemostatic changes are not uncommon in patients with chronic renal failure, affecting thedifferent parameter hemostasis so it should be consider in the management of these patients.
Background: Renal disease results in significant disorder of hemostasis (bleeding diathesis orhypercoagulable state).Objectives: This study is to determine the changes in some hemostasis parameters in patients withchronic renal failure and identify the effect of dialysis on these changes.Patients and Methods: seventy five patients with end stage chronic renal failure were collected fromBaghdad hospital, a full detailed history and clinical examination were performed, 50 patients were onmaintenance weekly hemodialysis, and 25 patients were without dialysis.Result: Bleeding time was significantly higher in patients with chronic renal failure who didn’t needany type of dialysis, positive D-Dimer test. In some patients, Platelet count, prothrombin time, thrombintime, fibrinogene level, activated partial thromboplastin time; all did not reach significant level betweenboth groups of patients.Conclusion: hemostatic changes are not uncommon in patients with chronic renal failure, affecting thedifferent parameter hemostasis so it should be consider in the management of these patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.